Marzeptacog Alfa (activated) Uses, Dosage, Side Effects and more

Marzeptacog Alfa (activated) is under investigation in clinical trial NCT01439971 (Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia).

Trade Name Marzeptacog Alfa (activated)
Generic Marzeptacog alfa (activated)
Marzeptacog alfa (activated) Other Names Marzeptacog alfa (activated), PF-05280602
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share